The move should be considered against the stock’s longer-term performance. ASX:CYC is down 38.38% over the past year. A single-session gain and a one-year return measure different periods, so both figures are useful when assessing the latest price action. Based strictly on the supplied …
Clarity Pharmaceuticals Ltd (ASX:CU6) attracted investor attention after its shares gained 2.08% to AUD 2.45 on 15 July 2026. Despite the positive trading session, the company's broader share price performance remains weaker over a longer period, with the stock still down 24.38% over the …
No company-specific catalyst has been confirmed for the recent move in Saluda Medical. In this window, there has been no verified market-moving ASX announcement, guidance adjustment or deal. The softness appears tied to a broad healthcare sell-off, a rotation of investor money back toward …
No company-specific catalyst has been confirmed for the recent move in Regis Healthcare. There has been no verified market-moving ASX announcement, guidance change or transaction in this window. The softness appears sector-led, tied to a broad healthcare sell-off and a rotation of investor money …
No fresh, company-specific catalyst has been confirmed for the recent move in ResMed. No market-moving ASX announcement, change to guidance or transaction has been verified in this window. Instead, the softness appears tied to a broad healthcare sell-off, a rotation of investor money back …
Cochlear Ltd (ASX:COH) has experienced one of the most dramatic shifts in investor sentiment among ASX healthcare stocks over the past year. Once regarded as one of the Australian market's most dependable healthcare growth stories, the company saw investor confidence shaken after softer trading …
dorsaVi Limited (ASX:DVL) has commenced the tape-out pathway for its first resistive random-access memory and complementary metal-oxide semiconductor validation chip, moving its 22-nanometre development program from finalised design into physical silicon implementation. The latest milestone is intended to provide the practical testing data required …
EMvision Medical Devices Limited (ASX:EMV) shares edged 0.98% higher to AUD 1.54 during the morning session on 15 July 2026 after the company released its quarterly activities and cash flow report for the three months ended 30 June 2026. The update outlined progress across …
Echoiq Ltd (ASX:EIQ) rose to $1.605, recording a session gain of +5.59%. EchoIQ shares gained to $1.605 in today’s session, with the move reflecting continued investor interest in the AI cardiac diagnostics platform.
Regis Healthcare fell to $5.77, recording a session decline of -4.15%. At this level, the stock is consolidating within its recent trading range, and the day’s fall brings it back toward the lower end. Aged care operators can be sensitive to regulatory news, labour …